Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
PRTA Transcript
Prothena Corporation plc (PRTA) Q4 2025 Earnings Call Transcript
Unknown2-19
The earnings call reflects a mixed sentiment. Financial performance shows prudent capital utilization but also a significant net loss. The Q&A highlights promising developments in product trials and partnerships, but also reveals management's reluctance to provide detailed guidance, creating uncertainty. The share redemption plan indicates potential shareholder value but lacks immediate impact. Overall, the stock is likely to remain neutral, with no strong catalysts for significant movement. The market cap suggests moderate sensitivity to these factors.
Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript
Unknown2-21
Earnings call shows EPS and net loss near lower guidance, no share repurchase, and uncertainties in AL amyloidosis treatment. Q&A reveals lack of specifics on critical issues and unclear management responses, indicating potential risks. Although management is optimistic about birtamimab's market potential, the financial metrics and lack of guidance clarity suggest a negative sentiment. Given the small-cap nature of the company, this could lead to a stock price decline of -2% to -8%.
Prothena Corporation plc (PRTA) Q4 2023 Earnings Call Transcript
Positive2-16
The company's financial performance was better than expected, with efficient resource management and strong cash reserves. The Q&A session highlighted positive trial developments, such as strong patient enrollment and promising safety profiles, despite some management evasiveness on specific data updates. These factors, combined with the company's market cap, suggest a positive stock price movement within the 2% to 8% range.
Prothena Corporation plc (PRTA) Q4 2022 Earnings Call Transcript
Neutral2-24
PRTA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
